Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14
Stock News
Yesterday
Fosun Pharma (HKEX: 02196) has announced that on September 14, 2026, the company repurchased 1.455 million shares at a total cost of HK$24.7051 million.
The buyback reflects the company's ongoing capital management strategy, aimed at enhancing shareholder value. The repurchased shares are expected to be canceled or held as treasury stock, depending on regulatory requirements and the board's discretion.
This transaction underscores Fosun Pharma's commitment to optimizing its capital structure while maintaining sufficient liquidity for future growth initiatives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.